Condition
Mouth Disease
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed3
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06882564Phase 3Recruiting
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
NCT06040164Unknown
Oral Endocannabinoids in People With Prediabetes and Diabetes
NCT00001648Completed
Structure of the Herpes Simplex Virus Receptor
NCT00228280Phase 1Unknown
Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling
NCT00001601Not ApplicableCompleted
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001952Completed
Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth
Showing all 6 trials